Saxagliptin is an active pharmaceutical ingredient that functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It is a monocarboxylic acid amide used in its monohydrate form as a hypoglycemic agent for the management of Type II diabetes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 361442-04-8
Saxagliptin hydrochloride
pharmaceutical raw material
Saxagliptin hydrate
pharmaceutical raw material
7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]-5-heptenoic acid
pharmaceutical raw material
Tramadol hydrochloride
pharmaceutical raw material
Prostaglandin E2
pharmaceutical raw material
Magnesium gluconate
pharmaceutical raw material
N-[(1S)-2-[(1S,3S,5S)-3-Cyano-2-azabicyclo[3.1.0]hex-2-yl]-1-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)-2-oxoethyl]carbamic acid 1,1-dimethylethyl ester
pharmaceutical raw material
Saxagliptin intermediate 6
pharmaceutical intermediate
(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
QGJUIPDUBHWZPV-SGTAVMJGSA-N
C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34CC5CC(C3)CC(C5)(C4)O)N